Histologic, immunohistochemical, and ultrastructural findings in a case of minocycline-associated "black thyroid"

Endocrine Pathology

Volumn 12, Issue 4, 2001, Pages 443-451

  Bell, C David ^a,b   Kovacs, Kalman ^a,b   Horvath, Eva ^a,b   Rotondo, Fabio ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Histology; Immunohistochemistry; Minocycline; Thyroid; Ultrastructure

Indexed keywords

MELANIN; MINOCYCLINE; THYROGLOBULIN; UBIQUITIN; VIMENTIN;

ADULT; ARTICLE; BLACK THYROID GLAND; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYSOSOME; PIGMENTATION; PRIORITY JOURNAL; STAINING; THYROID CELL; THYROID GLAND; ULTRASTRUCTURE;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MINOCYCLINE; PIGMENTATION DISORDERS; PIGMENTS, BIOLOGICAL; THYROGLOBULIN; THYROID DISEASES; THYROID GLAND; VIMENTIN;

EID: 0035731384     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:12:4:443     Document Type: Article

References (28)

1. A black thyroid and minocycline treatment
2. Black thyroid: Clinical manifestations, ultrastructural findings, and possible mechanisms
3. Papillary carcinoma associated with black thyroid gland
4. Hypopigmentation of a papillary carcinoma arising in a black thyroid
5. Abnormal iodoprotein distribution and resistance to proteolysis in Gunn rat black thyroid: An ultrastructural and biochemical study
6. Thyroid gland pigmentation and minocycline therapy
7. Fine structural aspects of the black thyroid induced by minocycline, and the effects of a low iodine diet, propylthiouracil, thyroxine tablet and TSH, on the black discoloration of the rat thyroid
8. Minocycline and the thyroid: Antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland
9. M30 expression demonstrates apoptotic cells, correlates with in situ end-labelling, and is associated with Ki-67 expression in large intestinal neoplasms
10. The black thyroid: Its relation to minocycline use in man
11. The black thyroid associated with minocycline therapy: A local manifestation of a drug-induced lysosome/substrate disorder
12. Black thyroid syndrome: Exaggeration of a normal process?
13. Intracellular protein catabolism: Evidence for sequestration of proteins into an intermediate-filament fraction before lysosomal degradation
14. Changes in the organization of the intermediate filament system of human fibroblasts in lysosomal storage diseases and their modeling
15. Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments
16. Efficient interaction of nonpolar lipids with intermediate filaments of the vimentin type
17. Vimentin and lipid metabolism
18. Attachment of steroidogenic lipid droplets to intermediate filaments in adrenal cells
19. Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts
20. Influence of phospholipids on the formation and stability of vimentin-type intermediate filaments
21. An electron microscopic study of the interaction in vitro of vimentin intermediate filaments with vesicles prepared from Erlich ascites tumor cell lipids
22. Intermediate filaments and ubiquitin: A new thread in the understanding of chronic neurodegenerative diseases
23. Intermediate filament proteins in nonfilamentous structures: Transient disintegration and inclusion of subunit proteins in granular aggregates
24. Ubiquitin, cellular inclusions and their role in neurodegeneration
25. Ubiquitin and the lysosome system; molecular immunopathology reveals the connection
26. Regulation of the GI to S transition by the ubiquitin pathway
27. Protein regulation by mono-ubiquitin
28. Thyrotropin regulates the levels of free ubiquitin and ubiquitin-protein conjugates in the male mouse thyroid